Strategic Blueprint LLC Raises Stock Holdings in Colgate-Palmolive (NYSE:CL)

Strategic Blueprint LLC raised its position in Colgate-Palmolive (NYSE:CL - Free Report) by 88.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,762 shares of the company's stock after acquiring an additional 5,993 shares during the quarter. Strategic Blueprint LLC's holdings in Colgate-Palmolive were worth $1,160,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CL. Forsta AP Fonden raised its position in shares of Colgate-Palmolive by 4.1% in the 4th quarter. Forsta AP Fonden now owns 256,500 shares of the company's stock worth $23,318,000 after purchasing an additional 10,100 shares during the last quarter. Sumitomo Life Insurance Co. boosted its stake in shares of Colgate-Palmolive by 34.2% during the 4th quarter. Sumitomo Life Insurance Co. now owns 13,800 shares of the company's stock worth $1,255,000 after acquiring an additional 3,517 shares during the last quarter. R Squared Ltd bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $165,000. Perigon Wealth Management LLC raised its holdings in Colgate-Palmolive by 3.6% in the 4th quarter. Perigon Wealth Management LLC now owns 33,677 shares of the company's stock worth $2,982,000 after purchasing an additional 1,184 shares during the period. Finally, VCI Wealth Management LLC lifted its position in Colgate-Palmolive by 46.9% during the fourth quarter. VCI Wealth Management LLC now owns 17,547 shares of the company's stock valued at $1,595,000 after purchasing an additional 5,599 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the company. Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Finally, TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of "Hold" and a consensus price target of $102.00.

Colgate-Palmolive Trading Up 0.8 %

NYSE:CL traded up $0.72 during mid-day trading on Thursday, hitting $90.29. 1,551,962 shares of the stock traded hands, compared to its average volume of 4,864,221. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $73.77 billion, a price-to-earnings ratio of 25.83, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The firm's 50 day moving average is $91.58 and its two-hundred day moving average is $97.29.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.22%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.34% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.